Reporting parties
Subject security
Symbol
ATHA
Shares outstanding
39,041,867 shares
Ownership signal
SEC evidence
Form type
SCHEDULE 13G
Filing time
16 Apr 2025, 16:22:18 UTC
Event date
14 Apr 2025
Next filing
10 Oct 2025
SEC filing
View on sec.gov

Key filing fact

Steven Michael Oliveira disclosed 5.1% ownership in Athira Pharma, Inc. Common Stock (ATHA) on 14 Apr 2025.

Key facts

  • Steven Michael Oliveira filed SCHEDULE 13G for Athira Pharma, Inc. Common Stock (ATHA).
  • Disclosed ownership: 5.1%.
  • Date of event: 14 Apr 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 Apr 2025, 16:22.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Steven Michael Oliveira 5.1% 1,994,649 0 1,994,649 /s/ Steven Michael Oliveira Steven Michael Oliveira
Nemean Asset Management, LLC 4.2% 1,644,649 0 1,644,649 /s/ Steven Oliveira Steven Oliveira, Authorized Signer
South Ocean Capital Management LLC 0.01% 250,000 0 250,000 /s/ Steven Oliveira Steven Oliveira, Authorized Signer
South Ocean Capital LLC 0% 100,000 0 100,000 /s/ Steven Oliveira Steven Oliveira, Authorized Signer
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .